LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Chen Schor, chief business officer of EPIX, is scheduled to co-chair a panel session along with a representative from GlaxoSmithKline entitled “GSK/EPIX: Leveraging Biotech Development Expertise To Create A Highly Collaborative, High-Value Partnership” at the BioBusiness 2008 Conference in Geneva, Switzerland on Wednesday, February 27, 2008 at 9:40 a.m. CET (Central European Time). Mr. Schor is also scheduled to serve as chairman of the Business Development Stream session of the conference later the same day beginning at 2:00 p.m. CET.
